E

Enumerix

Biotech & Life Sciences · Palo Alto, United States · Founded 2019

Enumerix is a pioneering company in the digital biology sector, offering cutting-edge PCR (Polymerase Chain Reaction) technology that simplifies and enhances molecular biology processes. The company serves molecular biology labs, researchers, and biotech firms by providing a unique spin column format that generates 30 million partitions per sample using a standard centrifuge. This technology offers 1500 times more partitions than conventional digital PCR, making it highly efficient for detecting rare molecules in diluted samples such as cell-free DNA (cfDNA). Enumerix operates in the genomics and biotechnology market, focusing on innovations that unlock simplicity, low cost, and high performance. The business model revolves around selling its proprietary UltraPCR technology and related consumables to labs and research institutions. Revenue is generated through the sale of these products and potentially through licensing agreements for their patented technologies. The company's multidisciplinary team boasts 60,000 citations and 100 patents, reflecting their proven success in the genomics space. Enumerix's mission is to revolutionize digital biology, making advanced molecular techniques accessible for everyday use. Keywords: digital biology, PCR technology, molecular biology, genomics, biotechnology, spin column, cfDNA, UltraPCR, high-performance, low-cost.